Andrew Lloyd Webber to trial coronavirus vaccine

Lawrence Kim
August 14, 2020

Andrew Lloyd Webber is anxious to get audiences back to the theater, which is why he's now taking part in a coronavirus vaccine trial from Oxford University and pharmaceutical company AstraZeneca.

"Just completed the Oxford Covid-19 vaccine trial".

Acclaimed composer Andrew Lloyd Webber, like many in the entertainment industry, is looking forward to the day when theaters can reopen safely.

A COVID-19 vaccine, ChAdOx1, is being developed by the University of Oxford in the United Kingdom in collaboration with the biopharmaceutical company AstraZeneca.

Meanwhile, the impresario of musical theatre has advocated for the safe reopening of theatres and live performance venues across the United Kingdom, and recently said the theatre industry finds itself in a "hopeless" scenario amid the pandemic. Lloyd Webber has been an active proponent of finding ways to attend the theater in the age of Covid.

He reflected: "It's a lot of money and we can't do it indefinitely".

Lloyd Webber, who is now working on the music for the postponed "Cinderella" musical, revealed he has been told theaters may open fully in November, but added, "No one can do that on the basis of an aspiration".

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER